Search

Embecta Corp

Open

SectorGezondheidszorg

6.17 -0.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.9

Max

6.23

Belangrijke statistieken

By Trading Economics

Inkomsten

25M

21M

Verkoop

50M

272M

K/W

Sectorgemiddelde

4.065

48.735

EPS

0.56

Dividendrendement

7.68

Winstmarge

7.766

Werknemers

1,850

EBITDA

20M

65M

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

7.68%

2.24%

Volgende Winsten

24 nov 2026

Volgende dividenddatum

17 dec 2026

Volgende Ex Dividend datum

4 dec 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

118M

339M

Vorige openingsprijs

6.81

Vorige sluitingsprijs

6.17

Embecta Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 okt 2026, 20:13 UTC

Embecta Corp's shares declined during after-market hours on Tuesday, maintaining a loss since the regular session close.

12 okt 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9 okt 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8 okt 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7 okt 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6 okt 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5 okt 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2 okt 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1 okt 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30 sep 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29 sep 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

28 sep 2026, 20:12 UTC

Embecta Corp is trading lower in after-market hours, continuing a decline since Monday, though it remains above its 20-day moving average.

25 sep 2026, 20:01 UTC

Embecta Corp is sharply higher, reaching a notable high and trading above its 20-day moving average, continuing an upward trend since Thursday's close.

24 sep 2026, 20:07 UTC

Embecta Corp's shares advanced modestly, remaining above the 20-day moving average and near the upper end of their one-month trading range.

22 sep 2026, 20:02 UTC

Embecta Corp is trading sharply higher, reaching a peak earlier in the session and remaining above its 20-day moving average.

21 sep 2026, 21:21 UTC

Embecta Corp is declining in after-market trading, reflecting a significant dip since Monday's close and currently positioned in the middle of its one-month trading range.

18 sep 2026, 20:04 UTC

Embecta Corp is trading higher, continuing its rise from Thursday and maintaining momentum above its 20-day moving average with three consecutive higher daily finishes.

16 sep 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 sep 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 sep 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 sep 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 sep 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 sep 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 sep 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 sep 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 sep 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 sep 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 aug 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 aug 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 aug 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

Peer Vergelijking

Prijswijziging

Embecta Corp Prognose

Beoordelingsconsensus

By TipRanks

Sell

2 ratings

0

Buy

1

Hold

1

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat